Cargando…

Expanding Access to Oral Preexposure Prophylaxis for People Who Inject Drugs in Bayelsa and Niger States, Nigeria

INTRODUCTION: While oral preexposure prophylaxis (PrEP) is recommended for all individuals with substantial risk of acquiring HIV, people who inject drugs (PWID) have not been prioritized for oral PrEP services in most settings. The Meeting Targets and Maintaining Epidemic Control (EpiC) project imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimoto, Lirica, Ikani, Patrick, Achanya, Joseph, Idowu, Adekunle, Olisa, Adaobi Lisa, Walker, Christa Fischer, Gottlieb, Amy, Akolo, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Global Health: Science and Practice 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972381/
https://www.ncbi.nlm.nih.gov/pubmed/36853631
http://dx.doi.org/10.9745/GHSP-D-22-00370
_version_ 1784898310319898624
author Nishimoto, Lirica
Ikani, Patrick
Achanya, Joseph
Idowu, Adekunle
Olisa, Adaobi Lisa
Walker, Christa Fischer
Gottlieb, Amy
Akolo, Christopher
author_facet Nishimoto, Lirica
Ikani, Patrick
Achanya, Joseph
Idowu, Adekunle
Olisa, Adaobi Lisa
Walker, Christa Fischer
Gottlieb, Amy
Akolo, Christopher
author_sort Nishimoto, Lirica
collection PubMed
description INTRODUCTION: While oral preexposure prophylaxis (PrEP) is recommended for all individuals with substantial risk of acquiring HIV, people who inject drugs (PWID) have not been prioritized for oral PrEP services in most settings. The Meeting Targets and Maintaining Epidemic Control (EpiC) project implemented a comprehensive community-based program to increase access to and uptake of oral PrEP services among PWID in Bayelsa and Niger States, Nigeria. PROGRAM DESCRIPTION: EpiC established partnerships with community-based organizations working with the PWID community, identified hotspots (common locations for socialization and drug use), and engaged PWID in tailoring oral PrEP services. The HIV prevention package provided in hotspots and drop-in centers included HIV testing, oral PrEP, postexposure prophylaxis, sexually transmitted infection screening and management, condoms and lubricants, PWID-specific risk reduction counseling, and referrals to other support programs. At drop-in centers, paralegal and psychological services were also provided. Peer outreach workers led outreach efforts. All PWID who tested HIV negative were eligible for oral PrEP screening. National oral PrEP eligibility criteria included: no suspicion of acute HIV infection, absence of proteinuria, and willingness to use oral PrEP as prescribed. We used descriptive analysis of routine programmatic data to illustrate program outcomes. RESULTS: From January 2020 to September 2021, 13,286 HIV tests were completed for PWID. Of these, 12,111 (91.16%) had negative results. Among those testing negative, 8,190 (67.62%) were screened for oral PrEP eligibility, and 2,661 (32.49%) were eligible. A total of 2,659 PWID (100% [312/312] among eligible females; 99.91% [2,347/2,349] among eligible males) initiated oral PrEP. LESSONS LEARNED: Provision of oral PrEP services to PWID in Nigeria is feasible through a peer-led, differentiated, and holistic approach that addresses structural barriers among the PWID community. Greater efforts are needed to understand the needs and barriers to better tailor HIV services to reach females and other subpopulations in this community that are harder to reach.
format Online
Article
Text
id pubmed-9972381
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Global Health: Science and Practice
record_format MEDLINE/PubMed
spelling pubmed-99723812023-03-01 Expanding Access to Oral Preexposure Prophylaxis for People Who Inject Drugs in Bayelsa and Niger States, Nigeria Nishimoto, Lirica Ikani, Patrick Achanya, Joseph Idowu, Adekunle Olisa, Adaobi Lisa Walker, Christa Fischer Gottlieb, Amy Akolo, Christopher Glob Health Sci Pract Program Case Study INTRODUCTION: While oral preexposure prophylaxis (PrEP) is recommended for all individuals with substantial risk of acquiring HIV, people who inject drugs (PWID) have not been prioritized for oral PrEP services in most settings. The Meeting Targets and Maintaining Epidemic Control (EpiC) project implemented a comprehensive community-based program to increase access to and uptake of oral PrEP services among PWID in Bayelsa and Niger States, Nigeria. PROGRAM DESCRIPTION: EpiC established partnerships with community-based organizations working with the PWID community, identified hotspots (common locations for socialization and drug use), and engaged PWID in tailoring oral PrEP services. The HIV prevention package provided in hotspots and drop-in centers included HIV testing, oral PrEP, postexposure prophylaxis, sexually transmitted infection screening and management, condoms and lubricants, PWID-specific risk reduction counseling, and referrals to other support programs. At drop-in centers, paralegal and psychological services were also provided. Peer outreach workers led outreach efforts. All PWID who tested HIV negative were eligible for oral PrEP screening. National oral PrEP eligibility criteria included: no suspicion of acute HIV infection, absence of proteinuria, and willingness to use oral PrEP as prescribed. We used descriptive analysis of routine programmatic data to illustrate program outcomes. RESULTS: From January 2020 to September 2021, 13,286 HIV tests were completed for PWID. Of these, 12,111 (91.16%) had negative results. Among those testing negative, 8,190 (67.62%) were screened for oral PrEP eligibility, and 2,661 (32.49%) were eligible. A total of 2,659 PWID (100% [312/312] among eligible females; 99.91% [2,347/2,349] among eligible males) initiated oral PrEP. LESSONS LEARNED: Provision of oral PrEP services to PWID in Nigeria is feasible through a peer-led, differentiated, and holistic approach that addresses structural barriers among the PWID community. Greater efforts are needed to understand the needs and barriers to better tailor HIV services to reach females and other subpopulations in this community that are harder to reach. Global Health: Science and Practice 2023-02-28 /pmc/articles/PMC9972381/ /pubmed/36853631 http://dx.doi.org/10.9745/GHSP-D-22-00370 Text en © Nishimoto et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited. To view a copy of the license, visit https://creativecommons.org/licenses/by/4.0/. When linking to this article, please use the following permanent link: https://doi.org/10.9745/GHSP-D-22-00370
spellingShingle Program Case Study
Nishimoto, Lirica
Ikani, Patrick
Achanya, Joseph
Idowu, Adekunle
Olisa, Adaobi Lisa
Walker, Christa Fischer
Gottlieb, Amy
Akolo, Christopher
Expanding Access to Oral Preexposure Prophylaxis for People Who Inject Drugs in Bayelsa and Niger States, Nigeria
title Expanding Access to Oral Preexposure Prophylaxis for People Who Inject Drugs in Bayelsa and Niger States, Nigeria
title_full Expanding Access to Oral Preexposure Prophylaxis for People Who Inject Drugs in Bayelsa and Niger States, Nigeria
title_fullStr Expanding Access to Oral Preexposure Prophylaxis for People Who Inject Drugs in Bayelsa and Niger States, Nigeria
title_full_unstemmed Expanding Access to Oral Preexposure Prophylaxis for People Who Inject Drugs in Bayelsa and Niger States, Nigeria
title_short Expanding Access to Oral Preexposure Prophylaxis for People Who Inject Drugs in Bayelsa and Niger States, Nigeria
title_sort expanding access to oral preexposure prophylaxis for people who inject drugs in bayelsa and niger states, nigeria
topic Program Case Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972381/
https://www.ncbi.nlm.nih.gov/pubmed/36853631
http://dx.doi.org/10.9745/GHSP-D-22-00370
work_keys_str_mv AT nishimotolirica expandingaccesstooralpreexposureprophylaxisforpeoplewhoinjectdrugsinbayelsaandnigerstatesnigeria
AT ikanipatrick expandingaccesstooralpreexposureprophylaxisforpeoplewhoinjectdrugsinbayelsaandnigerstatesnigeria
AT achanyajoseph expandingaccesstooralpreexposureprophylaxisforpeoplewhoinjectdrugsinbayelsaandnigerstatesnigeria
AT idowuadekunle expandingaccesstooralpreexposureprophylaxisforpeoplewhoinjectdrugsinbayelsaandnigerstatesnigeria
AT olisaadaobilisa expandingaccesstooralpreexposureprophylaxisforpeoplewhoinjectdrugsinbayelsaandnigerstatesnigeria
AT walkerchristafischer expandingaccesstooralpreexposureprophylaxisforpeoplewhoinjectdrugsinbayelsaandnigerstatesnigeria
AT gottliebamy expandingaccesstooralpreexposureprophylaxisforpeoplewhoinjectdrugsinbayelsaandnigerstatesnigeria
AT akolochristopher expandingaccesstooralpreexposureprophylaxisforpeoplewhoinjectdrugsinbayelsaandnigerstatesnigeria